Harte-Hanks (HHS) Misses Q4 EPS by 64c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $3.68 +1.94%
Financial Fact:
Total nonoperating expenses (income): 814K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total nonoperating expenses (income): 814K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q4 EPS of ($0.33), $0.64 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $47.13 million versus the consensus estimate of $50.1 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Sigma Lithium resumes full operations after signing TAC agreement
- Myriad Uranium completes acquisition of Rush Rare Metals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
